Zoono Group Ltd is a biotechnology company listed on the Australian Stock Exchange (ASX: ZNO) that has broad-spectrum antimicrobial protection technology which is effective against a wide range of disease-causing bacteria. 

The company has embarked on an ambitious global rollout of its range of products and after a period of bedding distribution channels down, has caught the attention of industry users of antibacterial products and investors alike.

When applied to a surface by spraying, wiping or ‘fogging’; Zoono leaves behind a mono-molecular layer that permanently bonds to the surface. These molecules are antimicrobial, silane based polymers that covalently bond to the surface forming a barrier of positively charged microscopic pins.

The positively charged microscopic pins attract and pierce negatively charged pathogens. The pins rupture the cell walls. This causes the pathogen to break up with lethal effect. The layer of molecular antimicrobial pins carries on working for up to 30 days on surfaces. Routine cleaning can continue and does not disrupt the Zoono molecule or its antimicrobial activity.

The simplest analogy is that antimicrobial “spikes” are formed on the surface that are highly positively charged and as a result of this charge, the negatively charged molecular structure of microorganisms are attracted to the “spikes” and the cell wall and membrane is lysed; the organism is then killed and the process continues.


The company made the following announcement to the Australian Stock Exchange on 14th October 2019 and confirmed them forging ahead strongly with their global rollout plans.

Third Quarter Update 

To learn more about the company, visit the website here: https://zoono.com

Author: Tony Adams

Disclosure: The writer and immediate associates hold shares in the company.